Sfoglia per Autore
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
2019-01-01 Mannavola, Francesco; D'Oronzo, Stella; Cives, Mauro; Stucci, LUIGIA STEFANIA; Ranieri, Girolamo; Silvestris, Francesco; Tucci, MARCO GAETANO
Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors
2019-01-01 Strosberg, Jonathan Raphael; Al-Toubah, Taymeyah; Cives, Mauro
EPB41L5 is Associated with the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors
2019-01-01 Saller, J.; Seydafkan, S.; Shahid, M.; Gadara, M.; Cives, M.; Eschrich, S. A.; Boulware, D.; Strosberg, J. R.; Aejaz, N.; Coppola, D.
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells.
2019-01-01 Tucci, M; Passarelli, A; Mannavola, F; Felici, C; Stucci, Ls; Cives, M; Silvestris, F
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors.
2019-01-01 Cives, M; Pelle', E; Quaresmini, D; Mandriani, Barbara; Tucci, M; Silvestris, F.
An Immunohistochemical Score as Predictor of the Bone Metastasis Risk in Patients with NETs
2019-01-01 Pelle, E; Cives, M; Ingravallo, G; Coppola, D; Rizzo, Fm; Maggio, I; Panzuto, F; Strosberg, J; Campana, D; Meyer, T; Resta, L; Silvestris, F
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer
2020-01-01 D’Oronzo, Stella; Silvestris, Erica; Paradiso, Angelo; Cives, Mauro; Tucci, Marco
Non-melanoma skin cancers: Biological and clinical features
2020-01-01 Cives, M.; Mannavola, F.; Lospalluti, L.; Sergi, M. C.; Cazzato, G.; Filoni, E.; Cavallo, F.; Giudice, G.; Stucci, L. S.; Porta, C.; Tucci, M.
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study
2020-01-01 Partelli, S.; Ramage, J. K.; Massironi, S.; Zerbi, A.; Kim, H. B.; Niccoli, P.; Panzuto, F.; Landoni, L.; Tomazic, A.; Ibrahim, T.; Kaltsas, G.; Bertani, E.; Sauvanet, A.; Segelov, E.; Caplin, M.; Coppa, J.; Armstrong, T.; Weickert, M. O.; Butturini, G.; Staettner, S.; Boesch, F.; Cives, M.; Moulton, C. A.; He, J.; Selberherr, A.; Twito, O.; Castaldi, A.; De Angelis, C. G.; Gaujoux, S.; Almeamar, H.; Frilling, A.; Vigia, E.; Wilson, C.; Muffatti, F.; Srirajaskanthan, R.; Invernizzi, P.; Lania, A.; Kwon, W.; Ewald, J.; Rinzivillo, M.; Nessi, C.; Smid, L. M.; Gardini, A.; Tsoli, M.; Picardi, E. E.; Hentic, O.; Croagh, D.; Toumpanakis, C.; Citterio, D.; Ramsey, E.; Mosterman, B.; Regi, P.; Gasteiger, S.; Rossi, R. E.; Smiroldo, V.; Jang, J. -Y.; Falconi, M.
A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms
2020-01-01 Al-Toubah, T.; Schell, M. J.; Cives, M.; Zhou, J. -M.; Soares, H. P.; Strosberg, J. R.
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When KI-67 is ≥10%?
2020-01-01 Merola, E; Alonso Gordoa, T; Zhang, P; Al-Toubah, T; Pelle, E; Kolasińska-Ćwikła, A; Zandee, W T; Laskaratos, F M; de Mestier, L; Lamarca, A; Hernando, J; Cwikla, J B; Strosberg, J; de Herder, W W; Caplin, M; Cives, M; van Leeuwaarde, R S
Sensitivity and Specificity of the NETest: A Validation Study
2020-01-01 Al-Toubah, Taymeyah; Cives, Mauro; Valone, Tiffany; Blue, Kirsten; Strosberg, Jonathan R.
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
2020-01-01 Panzuto, F.; Maccauro, M.; Campana, D.; Faggiano, A.; Massironi, S.; Pusceddu, S.; Spada, F.; Ferone, D.; Modica, R.; Grana, C. M.; Ferolla, P.; Rinzivillo, M.; Badalamenti, G.; Zatelli, M. C.; Gelsomino, F.; De Carlo, E.; Bartolomei, M.; Brizzi, M. P.; Cingarlini, S.; Versari, A.; Fanciulli, G.; Arvat, E.; Merola, E.; Cives, M.; Tafuto, S.; Baldari, S.; Falconi, M.
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors
2020-01-01 Cives, Mauro; Pelle', Eleonora; Strosberg, Jonathan
BONE METASTASES IN NEUROENDOCRINE TUMORS: MOLECULAR PATHOGENESIS AND IMPLICATIONS IN CLINICAL PRACTICE.
2020-01-01 Cives, M; Pelle', E; Rinzivillo, M; Prosperi, D; Tucci, M; Silvestris, F; Panzuto, F
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients
2020-01-01 D'Oronzo, S; Lovero, D; Palmirotta, R; Cafforio, P; Brown, J; Wood, S; Cives, M; Tucci, M; Stucci, Ls; Coleman, Re; Silvestris, F.
Novel immunotherapy strategies for treatment of neuroendocrine neoplasms
2020-01-01 Al-Toubah, T.; Cives, M.; Strosberg, J.
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours
2021-01-01 Dawod, M.; Gordoa, T. A.; Cives, M.; De Mestier, L.; Crona, J.; Spada, F.; Oberg, K.; Pavel, M.; Lamarca, A.
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment
2021-01-01 Lamarca, Angela; Cives, Mauro; de Mestier, Louis; Crona, Joakim; Spada, Francesca; Öberg, Kjell; Pavel, Marianne; Alonso-Gordoa, Teresa
The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability
2021-01-01 Lauricella, E.; Cives, M.; Bracigliano, A.; Clemente, O.; Felici, V.; Lippolis, R.; Amoruso, B.; Pelle', E.; Mandriani, B.; Esposto, C.; Forte, C.; Perri, F.; Porta, C.; Tafuto, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression | 1-gen-2019 | Mannavola, Francesco; D'Oronzo, Stella; Cives, Mauro; Stucci, LUIGIA STEFANIA; Ranieri, Girolamo; Silvestris, Francesco; Tucci, MARCO GAETANO | |
| Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors | 1-gen-2019 | Strosberg, Jonathan Raphael; Al-Toubah, Taymeyah; Cives, Mauro | |
| EPB41L5 is Associated with the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors | 1-gen-2019 | Saller, J.; Seydafkan, S.; Shahid, M.; Gadara, M.; Cives, M.; Eschrich, S. A.; Boulware, D.; Strosberg, J. R.; Aejaz, N.; Coppola, D. | |
| Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. | 1-gen-2019 | Tucci, M; Passarelli, A; Mannavola, F; Felici, C; Stucci, Ls; Cives, M; Silvestris, F | |
| The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. | 1-gen-2019 | Cives, M; Pelle', E; Quaresmini, D; Mandriani, Barbara; Tucci, M; Silvestris, F. | |
| An Immunohistochemical Score as Predictor of the Bone Metastasis Risk in Patients with NETs | 1-gen-2019 | Pelle, E; Cives, M; Ingravallo, G; Coppola, D; Rizzo, Fm; Maggio, I; Panzuto, F; Strosberg, J; Campana, D; Meyer, T; Resta, L; Silvestris, F | |
| Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer | 1-gen-2020 | D’Oronzo, Stella; Silvestris, Erica; Paradiso, Angelo; Cives, Mauro; Tucci, Marco | |
| Non-melanoma skin cancers: Biological and clinical features | 1-gen-2020 | Cives, M.; Mannavola, F.; Lospalluti, L.; Sergi, M. C.; Cazzato, G.; Filoni, E.; Cavallo, F.; Giudice, G.; Stucci, L. S.; Porta, C.; Tucci, M. | |
| Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study | 1-gen-2020 | Partelli, S.; Ramage, J. K.; Massironi, S.; Zerbi, A.; Kim, H. B.; Niccoli, P.; Panzuto, F.; Landoni, L.; Tomazic, A.; Ibrahim, T.; Kaltsas, G.; Bertani, E.; Sauvanet, A.; Segelov, E.; Caplin, M.; Coppa, J.; Armstrong, T.; Weickert, M. O.; Butturini, G.; Staettner, S.; Boesch, F.; Cives, M.; Moulton, C. A.; He, J.; Selberherr, A.; Twito, O.; Castaldi, A.; De Angelis, C. G.; Gaujoux, S.; Almeamar, H.; Frilling, A.; Vigia, E.; Wilson, C.; Muffatti, F.; Srirajaskanthan, R.; Invernizzi, P.; Lania, A.; Kwon, W.; Ewald, J.; Rinzivillo, M.; Nessi, C.; Smid, L. M.; Gardini, A.; Tsoli, M.; Picardi, E. E.; Hentic, O.; Croagh, D.; Toumpanakis, C.; Citterio, D.; Ramsey, E.; Mosterman, B.; Regi, P.; Gasteiger, S.; Rossi, R. E.; Smiroldo, V.; Jang, J. -Y.; Falconi, M. | |
| A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms | 1-gen-2020 | Al-Toubah, T.; Schell, M. J.; Cives, M.; Zhou, J. -M.; Soares, H. P.; Strosberg, J. R. | |
| Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When KI-67 is ≥10%? | 1-gen-2020 | Merola, E; Alonso Gordoa, T; Zhang, P; Al-Toubah, T; Pelle, E; Kolasińska-Ćwikła, A; Zandee, W T; Laskaratos, F M; de Mestier, L; Lamarca, A; Hernando, J; Cwikla, J B; Strosberg, J; de Herder, W W; Caplin, M; Cives, M; van Leeuwaarde, R S | |
| Sensitivity and Specificity of the NETest: A Validation Study | 1-gen-2020 | Al-Toubah, Taymeyah; Cives, Mauro; Valone, Tiffany; Blue, Kirsten; Strosberg, Jonathan R. | |
| Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) | 1-gen-2020 | Panzuto, F.; Maccauro, M.; Campana, D.; Faggiano, A.; Massironi, S.; Pusceddu, S.; Spada, F.; Ferone, D.; Modica, R.; Grana, C. M.; Ferolla, P.; Rinzivillo, M.; Badalamenti, G.; Zatelli, M. C.; Gelsomino, F.; De Carlo, E.; Bartolomei, M.; Brizzi, M. P.; Cingarlini, S.; Versari, A.; Fanciulli, G.; Arvat, E.; Merola, E.; Cives, M.; Tafuto, S.; Baldari, S.; Falconi, M. | |
| Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors | 1-gen-2020 | Cives, Mauro; Pelle', Eleonora; Strosberg, Jonathan | |
| BONE METASTASES IN NEUROENDOCRINE TUMORS: MOLECULAR PATHOGENESIS AND IMPLICATIONS IN CLINICAL PRACTICE. | 1-gen-2020 | Cives, M; Pelle', E; Rinzivillo, M; Prosperi, D; Tucci, M; Silvestris, F; Panzuto, F | |
| In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients | 1-gen-2020 | D'Oronzo, S; Lovero, D; Palmirotta, R; Cafforio, P; Brown, J; Wood, S; Cives, M; Tucci, M; Stucci, Ls; Coleman, Re; Silvestris, F. | |
| Novel immunotherapy strategies for treatment of neuroendocrine neoplasms | 1-gen-2020 | Al-Toubah, T.; Cives, M.; Strosberg, J. | |
| Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours | 1-gen-2021 | Dawod, M.; Gordoa, T. A.; Cives, M.; De Mestier, L.; Crona, J.; Spada, F.; Oberg, K.; Pavel, M.; Lamarca, A. | |
| Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment | 1-gen-2021 | Lamarca, Angela; Cives, Mauro; de Mestier, Louis; Crona, Joakim; Spada, Francesca; Öberg, Kjell; Pavel, Marianne; Alonso-Gordoa, Teresa | |
| The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability | 1-gen-2021 | Lauricella, E.; Cives, M.; Bracigliano, A.; Clemente, O.; Felici, V.; Lippolis, R.; Amoruso, B.; Pelle', E.; Mandriani, B.; Esposto, C.; Forte, C.; Perri, F.; Porta, C.; Tafuto, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile